RxDoctor Payments Data

Nicholas Cote, DO

Family Medicine · Murfreesboro, TNNPI 1649426016

Payments from drug & device makers

$8,615in general payments, 2019–2025

Across 556 payments — averaging $15.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$1K
  • Astellas Pharma US Inc$865
  • Amgen$751
  • Otsuka America Pharmaceutical, Inc.$723
  • Pfizer$515
  • plus $3K from 34 others

What the payments were for

  • Food & beverage$8,51299%
  • Education$1031%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,615 in reported general payments places this provider in the 85th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$104,633
Medicare patients
177
Services billed
5,160

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide92$141,098
MounjaroTirzepatide85$93,996
EliquisApixaban72$66,255
Synjardy XrEmpagliflozin/Metformin Hcl54$45,340
Xultophy 100-3.6Insulin Degludec/Liraglutide21$42,351
XareltoRivaroxaban43$36,385
JardianceEmpagliflozin29$33,202
Tresiba Flextouch U-200Insulin Degludec12$20,087
Repatha SureclickEvolocumab27$20,018
Xigduo XrDapaglifloz Propaned/Metformin32$18,558
Soliqua 100-33Insulin Glargine/Lixisenatide14$17,137
MyrbetriqMirabegron26$16,784
Tresiba Flextouch U-100Insulin Degludec24$15,962
ShingrixVaricella-Zoster Ge/As01b/Pf45$9,786
Rosuvastatin Calcium443$6,758

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Xultophy 100-3.6$1,642$183,448113 claims
Lilly USA, LLCMounjaro$75$93,99685 claims
Boehringer IngelheimSynjardy Xr, Jardiance$235$78,54283 claims
PfizerEliquis$515$66,25572 claims
Johnson & JohnsonXarelto$142$36,38543 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$16$17,13714 claims
Astellas Pharma US IncMyrbetriq$865$16,78426 claims
GSKShingrix, Arexvy$209$15,49063 claims
AbbVieSynthroid$1,356$4,18279 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Murfreesboro

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →